Abstract
While the origins of sudden sensorineural hearing loss remain unproven and treatment empirical, the most appropriate therapy remains a matter of controversy. In this paper we have analysed the current forms of treatment, i.e. diatrizoate meglumine, steroids and a vasodilator. The results suggest that although several related factors were shown to indicate a good prognosis regardless of the therapy, none of the currently available regimens produces consistently better results than the spontaneous recovery rate of 65% reported by Mattox & Simmons.
| Original language | English |
|---|---|
| Pages (from-to) | 45-51 |
| Number of pages | 7 |
| Journal | Clinical Otolaryngology and Allied Sciences |
| Volume | 14 |
| Issue number | 1 |
| Publication status | Published - 1989 |
| Externally published | Yes |
ASJC Scopus subject areas
- Otorhinolaryngology
Fingerprint Dive into the research topics of 'Hypaque and steroids in the treatment of sudden sensorineural hearing loss'. Together they form a unique fingerprint.
Cite this
Huang, T. S., Chan, S. T., Ho, T. L., Su, J. L., & Lee, F. P. (1989). Hypaque and steroids in the treatment of sudden sensorineural hearing loss. Clinical Otolaryngology and Allied Sciences, 14(1), 45-51.